Annual Shareholders Equity
$327.94 M
+$148.52 M+82.78%
December 31, 2023
Summary
- As of February 8, 2025, ALPN annual stockholders equity is $327.94 million, with the most recent change of +$148.52 million (+82.78%) on December 31, 2023.
- During the last 3 years, ALPN annual shareholders equity has risen by +$265.78 million (+427.59%).
Performance
ALPN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$332.70 M
+$4.76 M+1.45%
March 1, 2024
Summary
- As of February 8, 2025, ALPN quarterly stockholders equity is $332.70 million, with the most recent change of +$4.76 million (+1.45%) on March 1, 2024.
- Over the past year, ALPN quarterly shareholders equity has increased by +$171.07 million (+105.84%).
Performance
ALPN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ALPN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.8% | +105.8% |
| 3 y3 years | +427.6% | +105.8% |
| 5 y5 years | +635.4% | +105.8% |
ALPN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -63.1% | at high | -70.1% |
| 5 y | 5-year | at high | -91.0% | at high | -95.1% |
| alltime | all time | at high | -127.8% | at high | -106.0% |
Alpine Immune Sciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $332.70 M(+1.5%) |
| Dec 2023 | $327.94 M(+82.8%) | $327.94 M(+102.9%) |
| Sep 2023 | - | $161.63 M(-4.6%) |
| Jun 2023 | - | $169.39 M(-0.1%) |
| Mar 2023 | - | $169.54 M(-5.5%) |
| Dec 2022 | $179.42 M(+48.4%) | $179.42 M(-1.4%) |
| Sep 2022 | - | $182.01 M(+82.9%) |
| Jun 2022 | - | $99.54 M(-13.8%) |
| Mar 2022 | - | $115.43 M(-4.5%) |
| Dec 2021 | $120.90 M(+94.5%) | $120.90 M(-1.6%) |
| Sep 2021 | - | $122.83 M(+180.2%) |
| Jun 2021 | - | $43.83 M(-17.8%) |
| Mar 2021 | - | $53.29 M(-14.3%) |
| Dec 2020 | $62.16 M(+110.9%) | $62.16 M(-7.9%) |
| Sep 2020 | - | $67.47 M(+315.8%) |
| Jun 2020 | - | $16.23 M(-34.7%) |
| Mar 2020 | - | $24.86 M(-15.7%) |
| Dec 2019 | $29.47 M | $29.47 M(-15.4%) |
| Sep 2019 | - | $34.83 M(-23.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $45.42 M(-19.7%) |
| Mar 2019 | - | $56.58 M(+26.9%) |
| Dec 2018 | $44.59 M(-43.5%) | $44.59 M(-18.9%) |
| Sep 2018 | - | $54.98 M(-17.4%) |
| Jun 2018 | - | $66.55 M(-9.9%) |
| Mar 2018 | - | $73.88 M(-6.4%) |
| Dec 2017 | $78.92 M(+42.4%) | $78.92 M(-4.9%) |
| Sep 2017 | - | $82.97 M(+80.1%) |
| Jun 2017 | - | $46.07 M(-6.4%) |
| Mar 2017 | - | $49.22 M(-11.2%) |
| Dec 2016 | $55.44 M(-33.6%) | $55.44 M(-10.7%) |
| Sep 2016 | - | $62.10 M(-9.6%) |
| Jun 2016 | - | $68.69 M(-10.0%) |
| Mar 2016 | - | $76.36 M(-8.5%) |
| Dec 2015 | $83.49 M(-630.0%) | $83.49 M(-6.6%) |
| Sep 2015 | - | $89.38 M(-6.0%) |
| Jun 2015 | - | $95.12 M(-577.6%) |
| Mar 2015 | - | -$19.92 M(+26.4%) |
| Dec 2014 | -$15.75 M(-82.7%) | -$15.75 M |
| Dec 2013 | -$91.29 M | - |
FAQ
- What is Alpine Immune Sciences annual stockholders equity?
- What is the all time high annual shareholders equity for Alpine Immune Sciences?
- What is Alpine Immune Sciences annual shareholders equity year-on-year change?
- What is Alpine Immune Sciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Alpine Immune Sciences?
- What is Alpine Immune Sciences quarterly shareholders equity year-on-year change?
What is Alpine Immune Sciences annual stockholders equity?
The current annual shareholders equity of ALPN is $327.94 M
What is the all time high annual shareholders equity for Alpine Immune Sciences?
Alpine Immune Sciences all-time high annual stockholders equity is $327.94 M
What is Alpine Immune Sciences annual shareholders equity year-on-year change?
Over the past year, ALPN annual stockholders equity has changed by +$148.52 M (+82.78%)
What is Alpine Immune Sciences quarterly stockholders equity?
The current quarterly shareholders equity of ALPN is $332.70 M
What is the all time high quarterly shareholders equity for Alpine Immune Sciences?
Alpine Immune Sciences all-time high quarterly stockholders equity is $332.70 M
What is Alpine Immune Sciences quarterly shareholders equity year-on-year change?
Over the past year, ALPN quarterly stockholders equity has changed by +$171.07 M (+105.84%)